The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

[HTML][HTML] Surveillance for late effects in childhood cancer survivors

W Landier, R Skinner, WH Wallace… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Many childhood cancer survivors carry a significant risk for late morbidity and mortality, a
consequence of the numerous therapeutic exposures that contribute to their cure. Focused …

State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3

U Siebert, O Alagoz, AM Bayoumi… - Medical Decision …, 2012 - journals.sagepub.com
State-transition modeling (STM) is an intuitive, flexible, and transparent approach of
computer-based decision-analytic modeling, including both Markov model cohort simulation …

[HTML][HTML] Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)

AI Adler, RJ Stevens, SE Manley, RW Bilous, CA Cull… - Kidney international, 2003 - Elsevier
Development and progression of nephropathy in type 2 diabetes: The United Kingdom
Prospective Diabetes Study (UKPDS 64). Background The progression of nephropathy from …

An introduction to Markov modelling for economic evaluation

A Briggs, M Sculpher - Pharmacoeconomics, 1998 - Springer
Markov models are often employed to represent stochastic processes, that is, random
processes that evolve over time. In a healthcare context, Markov models are particularly …

[图书][B] Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine

DB Petitti - 2000 - books.google.com
Meta-analysis, decision analysis, and cost-effectiveness analysis are the cornerstones of
evidence-based medicine. These related quantitative methods have become essential tools …

Handling uncertainty in cost-effectiveness models

AH Briggs - Pharmacoeconomics, 2000 - Springer
The use of modelling in economic evaluation is widespread, and it most often involves
synthesising data from a number of sources. However, even when economic evaluations are …

Modelling NAFLD disease burden in four Asian regions—2019‐2030

C Estes, HLY Chan, RN Chien… - Alimentary …, 2020 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis
(NASH) account for an increasing proportion of liver disease in the Asia‐Pacific region …

A taxonomy of model structures for economic evaluation of health technologies

A Brennan, SE Chick, R Davies - Health economics, 2006 - Wiley Online Library
Abstract Models for the economic evaluation of health technologies provide valuable
information to decision makers. The choice of model structure is rarely discussed in …

The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical …

AJ Palmer, S Roze, WJ Valentine… - … medical research and …, 2004 - Taylor & Francis
Objectives: We have developed an Internet-based, interactive computer model to determine
the longterm health outcomes and economic consequences of implementing different …